Statins reduce the neurofibrillary tangle burden in a mouse model of tauopathy

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · see citing works

Enzymatic determination of total serum cholesterol.

Allain, C. C., Poon, L. S., Chan, C. S. G., Richmond, W., & Fu, P. C. (1974) · Clinical Chemistry · doi:10.1093/clinchem/20.4.470 · Cited by 9,845 · see citing works

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668 · see citing works

PLEIOTROPIC EFFECTS OF STATINS

Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994 · see citing works

Turning Blood into Brain: Cells Bearing Neuronal Antigens Generated in Vivo from Bone Marrow

Mezey, É., Chandross, K. J., Harta, G., Maki, R. A., & McKercher, S. R. (2000) · Science · doi:10.1126/science.290.5497.1779 · Cited by 1,822 · see citing works

Statins and the risk of dementia

Jick, H., Zornberg, G. L., Jick, S. S., Seshadri, S. S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,763 · see citing works

A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity

Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388 · see citing works

Decreased Prevalence of Alzheimer Disease Associated With 3-Hydroxy-3-Methyglutaryl Coenzyme A Reductase Inhibitors

Wolozin, B. L. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1439 · Cited by 1,386 · see citing works

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

Youssef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,094 · see citing works

Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo

Fassbender, K. C., Simons, M., Bergmann, C., Stroick, M., Lütjohann, D., Keller, P., Runz, H., Kühl, S., Bertsch, T., von Bergmann, K., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081620098 · Cited by 1,078 · see citing works

Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice

Eglitis, M. A., & Mezey, É. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4080 · Cited by 1,015 · see citing works

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

Endres, M., Laufs, U., Huang, Z., Nakamura, T., Huang, P. L., Moskowitz, M. A., & Liao, J. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8880 · Cited by 957 · see citing works

Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils

Khoury, J. E., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., & Loike, J. D. (1996) · Nature · doi:10.1038/382716a0 · Cited by 727 · see citing works

Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease

Kitazawa, M., Oddo, S., Yamasaki, T. R., Green, K. N., & LaFerla, F. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2868-05.2005 · Cited by 697 · see citing works

Interleukin-1 Mediates Pathological Effects of Microglia on Tau Phosphorylation and on Synaptophysin Synthesis in Cortical Neurons through a p38-MAPK Pathway

Li, Y., Liu, L., Barger, S. W., & Griffin, W. S. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01605.2003 · Cited by 563 · see citing works

Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis

Benveniste, E. N. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050101 · Cited by 532 · see citing works

Use of Lipid-Lowering Agents, Indication Bias, and the Risk of Dementia in Community-Dwelling Elderly People

Rockwood, K. J., Kirkland, S., Hogan, D. B., MacKnight, C., Merry, H. R., Verreault, R., Wolfson, C. M., & McDowell, I. (2002) · Archives of Neurology · doi:10.1001/archneur.59.2.223 · Cited by 517 · see citing works

Atorvastatin for the Treatment of Mild to Moderate Alzheimer Disease

Sparks, D. L., Sabbagh, M. N., Connor, D. J., Lopez, J., Launer, L. J., Browne, P. J., Wasser, D., Johnson‐Traver, S., Lochhead, J. J., & Ziolwolski, C. (2005) · Archives of Neurology · doi:10.1001/archneur.62.5.753 · Cited by 392 · see citing works

Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease

Wolozin, B. L., Wang, S. W., Li, N.-C., Lee, A. F., Lee, T. A., & Kazis, L. E. (2007) · BMC Medicine · doi:10.1186/1741-7015-5-20 · Cited by 385 · see citing works

Do Statins Reduce Risk of Incident Dementia and Alzheimer Disease? The Cache County Study

Zandi, P. P. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.2.217 · Cited by 308 · see citing works

Statin Use and the Risk of Incident Dementia

Rea, T. D., Breitner, J. C. S., Psaty, B. M., Fitzpatrick, A. L., López, O. L., Newman, A. B., Hazzard, W. R., Zandi, P. P., Burke, G. L., Lyketsos, C. G., et al. (2005) · Archives of Neurology · doi:10.1001/archneur.62.7.1047 · Cited by 277 · see citing works

Statin therapy and risk of dementia in the elderly

Li, G., Higdon, R., Kukull, W. A., Peskind, E. R., Moore, K. V. V., Tsuang, D. W., van Belle, G., McCormick, W. C., Bowen, J. D., Teri, L. L., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000142963.90204.58 · Cited by 246 · see citing works

APOE genotype, cholesterol level, lipid-lowering treatment, and dementia

Dufouil, C., Richard, F., Fiévet, N., Dartigues, J., Ritchie, K. A., Tzourio, C., Amouyel, P., & Alpérovitch, A. (2005) · Neurology · doi:10.1212/01.wnl.0000160114.42643.31 · Cited by 229 · see citing works

Ezetimibe, a Potent Cholesterol Absorption Inhibitor, Inhibits the Development of Atherosclerosis in ApoE Knockout Mice

Davis, H. R., Compton, D. S., Hoos, L. M., & Tetzloff, G. G. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1201.100260 · Cited by 218 · see citing works

Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease

Oddo, S., Caccamo, A., Green, K. N., Liang, K., Tran, L., Chen, Y., Leslie, F. M., & LaFerla, F. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408500102 · Cited by 211 · see citing works

Microglial Activation parallels System Degeneration in progressive Supranuclear palsy and Corticobasal Degeneration

Ishizawa, K., & Dickson, D. W. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.6.647 · Cited by 209 · see citing works

In Vivo and in Vitro Blood–Brain Barrier Transport of 3-Hydroxy-3-Methylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitors

Saheki, A., Terasaki, T., Tamai, I., & Tsuji, A. (1994) · Pharmaceutical Research · doi:10.1023/a:1018975928974 · Cited by 206 · see citing works

Association between Statin Use and Alzheimer’s Disease

ZAMRINI, E. Y., McGwin, G., & Roseman, J. M. (2004) · Neuroepidemiology · doi:10.1159/000073981 · Cited by 201 · see citing works

Statins, incident Alzheimer disease, change in cognitive function, and neuropathology

Arvanitakis, Z., Schneider, J. A., Wilson, R. S., Bienias, J. L., Kelly, J. F., Evans, D. A., & Bennett, D. A. (2008) · Neurology · doi:10.1212/01.wnl.0000288181.00826.63 · Cited by 199 · see citing works

The Impact of the Use of Statins on the Prevalence of Dementia and the Progression of Cognitive Impairment

Hajjar, I. M., Schumpert, J., Hirth, V., Wieland, D. M., & Eleazer, G. P. (2002) · The Journals of Gerontology Series A · doi:10.1093/gerona/57.7.m414 · Cited by 188 · see citing works

Tauopathy-like Abnormalities and Neurologic Deficits in Mice Immunized With Neuronal Tau Protein

Rosenmann, H., Grigoriadis, N., Karussis, D., Boimel, M., Touloumi, O., Ovadia, H., & Abramsky, O. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1459 · Cited by 178 · see citing works

3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors Attenuate β-Amyloid-Induced Microglial Inflammatory Responses

Cordle, A. C., & Landreth, G. E. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2544-04.2005 · Cited by 177 · see citing works

Microglia as a Potential Bridge between the Amyloid β‐Peptide and Tau

Kitazawa, M., Yamasaki, T. R., & LaFerla, F. M. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.006 · Cited by 177 · see citing works

Simvastatin enhances learning and memory independent of amyloid load in mice

Li, L., Cao, D., Kim, H., Lester, R. A. J., & Fukuchi, K. (2006) · Annals of Neurology · doi:10.1002/ana.21053 · Cited by 150 · see citing works

Lovastatin enhances Aβ production and senile plaque deposition in female Tg2576 mice

Park, I.-H., Hwang, E. M., Hong, H., Boo, J. H., Oh, S. S., Lee, J., Jung, M. W., Bang, O. Y., Kim, S. U., & Mook‐Jung, I. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00155-0 · Cited by 124 · see citing works

Randomized trial of the effects of cholesterol-lowering dietary treatment on psychological function

Wardle, J., Rogers, P. J., Judd, P. A., Taylor, M. A., Rapoport, L., Green, M., & Perry, K. N. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00330-2 · Cited by 109 · see citing works

A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics

Rosenmann, H., Grigoriadis, N., Eldar-Levy, H., Avital, A., Rozenstein‐Tsalkovich, L., Touloumi, O., Behar, L., Ben‐Hur, T., Avraham, Y., Berry, E., et al. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.03.007 · Cited by 93 · see citing works

HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advise to use one that crosses the blood-brain barrier.

Sparks, D. L., Connor, D. J., Browne, P. J., Lopez, J. E., & Sabbagh, M. N. (2002) · PubMed · Cited by 82 · see citing works

Ezetimibe, a Potent Cholesterol Absorption Inhibitor, Normalizes Combined Dyslipidemia in Obese Hyperinsulinemic Hamsters

van Heek, M., Austin, T. M., Farley, C., Cook, J. A., Tetzloff, G. G., & Davis, H. R. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1330 · Cited by 79 · see citing works

Effects of Lovastatin and Pravastatin on Amyloid Processing and Inflammatory Response in TgCRND8 Brain

Chauhan, N. B., Siegel, G. J., & Feinstein, D. L. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000042217.90204.8d · Cited by 77 · see citing works

Atorvastatin‐induced activation of Alzheimer's α secretase is resistant to standard inhibitors of protein phosphorylation‐regulated ectodomain shedding

Parvathy, S., Ehrlich, M. E., Pedrini, S., Diaz, N. S., Refolo, L. M., Buxbaum, J. D., Bogush, A. I., Petanceska, S. S., & Gandy, S. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02521.x · Cited by 74 · see citing works

Hyperphosphorylation and Aggregation of Tau in Experimental Autoimmune Encephalomyelitis

Schneider, A., Araújo, G. W., Trajković, K., Herrmann, M. M., Merkler, D., Mandelkow, E., Weissert, R., & Simons, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409954200 · Cited by 72 · see citing works

Inhibition of Geranylgeranylation Mediates the Effects of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Inhibitors on Microglia

Bi, X., Baudry, M., Liu, J., Yao, Y., Fu, L., Brücher, F., & LYNCH, G. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405442200 · Cited by 69 · see citing works

Impact of HMG-CoA reductase inhibition on brain pathology

Zipp, F., Waiczies, S., Aktaş, O., Neuhaus, O., Hemmer, B., Schraven, B., Nitsch, R., & Hartung, H. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.05.001 · Cited by 65 · see citing works

The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-β1–42 in the rat hippocampus in vivo

Clarke, R. M., O'Connell, F., Lyons, A., & Lynch, M. A. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.07.031 · Cited by 63 · see citing works

Effects of statins on microglia

Lindberg, C., Crisby, M., Winblad, B. G., & Schultzberg, M. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20615 · Cited by 53 · see citing works

Basophilia, acidophilia and argyrophilia of “dark” (compacted) neurons during their formation, recovery or death in an otherwise undamaged environment

Zsombok, A., Tóth, Z., & Gallyas, F. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2004.08.005 · Cited by 53 · see citing works

Regulation of Intracellular Cholesterol Metabolism.

Sato, R., & Takano, T. (1995) · Cell Structure and Function · doi:10.1247/csf.20.421 · Cited by 52 · see citing works

Lovastatin modulation of microglial activation via suppression of functional CD40 expression

Townsend, K. P., Shytle, D., Bai, Y., San, N., Zeng, J., Freeman, M. J., Mori, T., Fernandez, F., Morgan, D., Sanberg, P. R., et al. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20234 · Cited by 52 · see citing works

Differential Effects of Amlodipine and Atorvastatin Treatment and Their Combination on Atherosclerosis in ApoE*3-Leiden Transgenic Mice

Delsing, D. J. M., Jukema, J. W., van de Wiel, M. A., EMEIS, J. J., van der Laarse, A., Havekes, L. M., & Princen, H. M. G. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200307000-00010 · Cited by 48 · see citing works

Gel-to-gel phase transition may occur in mammalian cells: Mechanism of formation of ?dark? (compacted) neurons

Gallyas, F., Farkas, O., & Mázló, M. (2004) · Biology of the Cell · doi:10.1016/j.biolcel.2004.01.009 · Cited by 32 · see citing works

Use of in Vivo Models to Study the Role of Cholesterol in the Etiology of Alzheimer's Disease

Burns, M. P., & Duff, K. (2003) · Neurochemical Research · doi:10.1023/a:1023294820218 · Cited by 23 · see citing works

Amyloid-β-independent regulators of tau pathology in Alzheimer disease

van der Kant, R., Goldstein, L. S. B., & Ossenkoppele, R. (2020) · Nature reviews. Neuroscience · doi:10.1038/s41583-019-0240-3 · Cited by 580 · see citing works

The Role of Tau in Alzheimer's Disease and Related Disorders

Medeiros, R., Baglietto‐Vargas, D., & LaFerla, F. M. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00177.x · Cited by 449 · see citing works

Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons

van der Kant, R., Langness, V. F., Herrera, C. M., Williams, D. A., Fong, L. K., Leestemaker, Y., Steenvoorden, E., Rynearson, K. D., Brouwers, J. F., Helms, J. B., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2018.12.013 · Cited by 350 · see citing works

A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease

Sano, M., Bell, K. L., Galasko, D., Galvin, J. E., Thomas, R. G., van Dyck, C. H., & Aisen, P. S. S. (2011) · Neurology · doi:10.1212/wnl.0b013e318228bf11 · Cited by 337 · see citing works

Insulin Resistance and Neurodegeneration: Progress towards the Development of New Therapeutics for Alzheimer's Disease

de la Monte, S. M. (2017) · Drugs · doi:10.1007/s40265-016-0674-0 · Cited by 331 · see citing works

What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer’s disease, about the therapeutic strategies in Alzheimer’s research

Šalković‐Petrišić, M., Knezović, A., Hoyer, S., & Riederer, P. F. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0877-9 · Cited by 271 · see citing works

Pharmacotherapy of Traumatic Brain Injury: State of the Science and the Road Forward: Report of the Department of Defense Neurotrauma Pharmacology Workgroup

Diaz-Arrastia, R. R., Kochanek, P. M., Bergold, P. J., Kenney, K., Marx, C. E., Grimes, C. J. B., Loh, Y., Adam, L. G. E., Oskvig, D., Curley, K. C., et al. (2013) · Journal of Neurotrauma · doi:10.1089/neu.2013.3019 · Cited by 260 · see citing works

Animal models in the drug discovery pipeline for Alzheimer's disease

Dam, D. V., & Deyn, P. P. D. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01299.x · Cited by 228 · see citing works

Statins Promote the Degradation of Extracellular Amyloid β-Peptide by Microglia via Stimulation of Exosome-associated Insulin-degrading Enzyme (IDE) Secretion

Tamboli, I. Y., Barth, E., Christian, L., Siepmann, M., Kumar, S., Singh, S., Tolksdorf, K., Heneka, M. T., Lütjohann, D., Wunderlich, P., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.149468 · Cited by 219 · see citing works

Age, vascular health, and Alzheimer disease biomarkers in an elderly sample

Vemuri, P., Lesnick, T. G., Przybelski, S. A., Knopman, D. S., Lowe, V. J., Graff‐Radford, J., Roberts, R. O., Mielke, M. M., Machulda, M. M., Petersen, R. C., et al. (2017) · Annals of Neurology · doi:10.1002/ana.25071 · Cited by 183 · see citing works

Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice

Boimel, M., Grigoriadis, N., Lourbopoulos, A., Haber, E., Abramsky, O., & Rosenmann, H. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.05.010 · Cited by 174 · see citing works

Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid‐life: A randomized trial

Hoscheidt, S. M., Sanderlin, A. H., Baker, L. D., Jung, Y., Lockhart, S. N., Kellar, D., Whitlow, C. T., Hanson, A. J., Friedman, S. D., Register, T. C., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12421 · Cited by 170 · see citing works

The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease

Sato, N., & Morishita, R. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00199 · Cited by 164 · see citing works

Is Alzheimer’s Disease Risk Modifiable?

Serrano‐Pozo, A., & Growdon, J. H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad181028 · Cited by 157 · see citing works

Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer’s disease

Jeong, A., Suazo, K. F., Wood, W. G., Distefano, M. D., & Li, L. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1458070 · Cited by 148 · see citing works

APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease

Barbero‐Camps, E., Fernández, A., Martínez-Gili, L., Fernández-Checa, J. C., & Colell, A. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt201 · Cited by 127 · see citing works

RhoA Signaling in Neurodegenerative Diseases

Schmidt, S. I., Blaabjerg, M., Freude, K., & Meyer, M. (2022) · Cells · doi:10.3390/cells11091520 · Cited by 110 · see citing works

Atorvastatin attenuates the production of IL-1β, IL-6, and TNF-α in the hippocampus of an amyloid β1-42-induced rat model of Alzheimer’s disease

Li, X.-H., Li, X.-H., Zhang, Y.-Y., Wang, M., & Wang, D. (2013) · Clinical Interventions in Aging · doi:10.2147/cia.s40405 · Cited by 108 · see citing works

Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice

Kurata, T., Miyazaki, K., Kozuki, M., Panin, V.-L., Morimoto, N., Ohta, Y., Nagai, M., Ikeda, Y., Matsuura, T., & Abe, K. (2011) · Brain Research · doi:10.1016/j.brainres.2010.11.067 · Cited by 98 · see citing works

Detrimental Effects of Diet-Induced Obesity on τ Pathology Are Independent of Insulin Resistance in τ Transgenic Mice

Leboucher, A., Laurent, C., Fernández-Gómez, F.-J., Burnouf, S., Troquier, L., Eddarkaoui, S., Demeyer, D., Caillierez, R., Zommer, N., Vallez, E., et al. (2012) · Diabetes · doi:10.2337/db12-0866 · Cited by 96 · see citing works

Animal models of Alzheimer's disease and drug development

Laurijssens, B. E., Aujard, F., & Rahman, A. (2012) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2012.04.001 · Cited by 92 · see citing works

Positive modulators of the α7 nicotinic receptor against neuroinflammation and cognitive impairment in Alzheimer's disease

Echeverrı́a, V., Iarkov, A., & Aliev, G. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.01.002 · Cited by 91 · see citing works

Targeting Aβ and tau in Alzheimer's disease, an early interim report

Golde, T. E., Petrucelli, L., & Lewis, J. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.035 · Cited by 89 · see citing works

Molecular Basis of Etiological Implications in Alzheimer’s Disease: Focus on Neuroinflammation

Niranjan, R. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8428-4 · Cited by 81 · see citing works

The Impact of Cholesterol, DHA, and Sphingolipids on Alzheimer’s Disease

Grimm, M. O. W., Zimmer, V. C., Lehmann, J., Grimm, H. S., & Hartmann, T. (2013) · BioMed Research International · doi:10.1155/2013/814390 · Cited by 81 · see citing works

Possible modification of Alzheimer’s disease by statins in midlife: interactions with genetic and non-genetic risk factors

Shinohara, M., Sato, N., Shimamura, M., Kurinami, H., Hamasaki, T., Chatterjee, A., Rakugi, H., & Morishita, R. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00071 · Cited by 59 · see citing works

Brain cholesterol and Alzheimer's disease: challenges and opportunities in probe and drug development

Ahmed, H., Wang, Y., Griffiths, W. J., Levey, A. I., Pikuleva, I. A., Liang, S. H., & Haider, A. (2024) · Brain · doi:10.1093/brain/awae028 · Cited by 57 · see citing works

Statin treatment affects cytokine release and phagocytic activity in primary cultured microglia through two separable mechanisms

Churchward, M. A., & Todd, K. G. (2014) · Molecular Brain · doi:10.1186/s13041-014-0085-7 · Cited by 57 · see citing works

Inhibition of neuronal cholesterol biosynthesis with lovastatin leads to impaired synaptic vesicle release even in the presence of lipoproteins or geranylgeraniol

Mailman, T. M., Hariharan, M., & Karten, B. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07474.x · Cited by 57 · see citing works

Statin-Regulated Efferocytosis in Physiological and Pathological Conditions

Tajbakhsh, A., Hayat, S. M. G., Askari, H., Savardashtaki, A., Pirro, M., Johnston, T. P., & Sahebkar, A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108282 · Cited by 55 · see citing works

Pitavastatin decreases tau levels via the inactivation of Rho/ROCK

Hamano, T., Yen, S.-H., Gendron, T., Ko, L.-W., & Kuriyama, M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.020 · Cited by 49 · see citing works

Association among Amyloid Plaque, Lipid, and Creatine in Hippocampus of TgCRND8 Mouse Model for Alzheimer Disease

Kuzyk, A. C., Kastyak, M. Z., Agrawal, V., Gallant, M., Gajjeraman, S., Rak, M., Bigio, M. R. D., Westaway, D. A., Julian, R., & Gough, K. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.142174 · Cited by 48 · see citing works

Alzheimer's Disease: Another Target for Heparin Therapy

Bergamaschini, L. C., Rossi, E., Vergani, C., & Simoni, M. G. D. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.100 · Cited by 46 · see citing works

The efficacy of statins in the treatment of Alzheimer’s disease: a meta-analysis of randomized controlled trial

Xuan, K., Zhao, T., Qu, G., Liu, H., Chen, X., & Sun, Y. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04243-6 · Cited by 45 · see citing works

The multifaceted role of WNT signaling in Alzheimer’s disease onset and age-related progression.

Kostes, W. W., & Brafman, D. A. (2023) · Cells · doi:10.3390/cells12081204 · Cited by 43 · see citing works

Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer’s Disease and Type 2 Diabetes

Infante‐Garcia, C., Ramos‐Rodríguez, J. J., Hierro‐Bujalance, C., Ortegon, E., Pickett, E. K., Jackson, R. J., Pacho, F. H., Spires‐Jones, T. L., & Garcı́a-Alloza, M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0825-7 · Cited by 41 · see citing works

Simvastatin Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy

Mountney, A., Bramlett, H. M., Dixon, C. E., Mondello, S., Dietrich, W. D., Wang, K., Caudle, K. L., Empey, P. E., Poloyac, S. M., Hayes, R. L., et al. (2015) · Journal of Neurotrauma · doi:10.1089/neu.2015.4130 · Cited by 40 · see citing works

Moderate Environmental Enrichment Mitigates Tauopathy in a Neurofibrillary Tangle Mouse Model

Lahiani-Cohen, I., Lourbopoulos, A. I., Haber, E., Rozenstein‐Tsalkovich, L., Abramsky, O., Grigoriadis, N., & Rosenmann, H. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318221bfab · Cited by 37 · see citing works

Dietary Cholesterol and Its Effect on Tau Protein: A Study in Apolipoprotein E-Deficient and P301L Human Tau Mice

Glöckner, F., Meske, V., Lütjohann, D., & Ohm, T. G. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318212f185 · Cited by 35 · see citing works

Statins in Neurological Disorders: Mechanisms and Therapeutic Value

Reiss, A. B., & Wirkowski, E. J. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.141 · Cited by 35 · see citing works

Atorvastatin and pitavastatin protect cerebellar Purkinje cells in AD model mice and preserve the cytokines MCP-1 and TNF-α

Kozuki, M., Kurata, T., Miyazaki, K., Morimoto, N., Ohta, Y., Ikeda, Y., & Abe, K. (2011) · Brain Research · doi:10.1016/j.brainres.2011.03.024 · Cited by 34 · see citing works

Amyloidosis and Neurodegenerative Diseases: Current Treatments and New Pharmacological Options

Tillement, J. P., Lecanu, L., & Papadopoulos, V. (2009) · Pharmacology · doi:10.1159/000259044 · Cited by 32 · see citing works

Atorvastatin in improvement of cognitive impairments caused by amyloid β in mice: involvement of inflammatory reaction

Zhao, L., Chen, T., Wang, C., Li, G., Zhi, W., Yin, J., Wan, Q., & Chen, L. (2016) · BMC Neurology · doi:10.1186/s12883-016-0533-3 · Cited by 32 · see citing works

Protein farnesylation is upregulated in Alzheimer’s human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer’s model mice

Jeong, A., Cheng, S., Zhong, R., Bennett, D. A., Bergö, M. O., & Li, L. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01231-5 · Cited by 30 · see citing works

Environmental Risk Factors for Progressive Supranuclear Palsy

Park, H. K., Ilango, S. D., & Litvan, I. (2021) · Journal of Movement Disorders · doi:10.14802/jmd.20173 · Cited by 29 · see citing works

Genetic Interaction between Tau and the Apolipoprotein E Receptor LRP1 Increases Alzheimer’s Disease Risk

Vázquez‐Higuera, J. L., Mateo, I., Sánchez‐Juan, P., Rodríguez‐Rodríguez, E., Pozueta, A., Infante, J., Berciano, J., & Combarros, O. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000234913 · Cited by 27 · see citing works

The Roles of Apolipoprotein E, Lipids, and Glucose in the Pathogenesis of Alzheimer’s Disease

Shinohara, M., & Sato, N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3540-2_5 · Cited by 26 · see citing works

Moderate- and Low-Dose of Atorvastatin Alleviate Cognition Impairment Induced by High-Fat Diet via Sirt1 Activation

Liu, H., Yang, J., Wang, K., Niu, T., & Huang, D. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02738-z · Cited by 24 · see citing works

Untangling Neurons With Endothelial Nitric Oxide

Iadecola, C. (2016) · Circulation Research · doi:10.1161/circresaha.116.309927 · Cited by 24 · see citing works

Low Endogenous and Chemical Induced Heat Shock Protein Induction in a 0N3Rtau-Expressing Drosophila Larval Model of Alzheimer's Disease

Sinadinos, C., Quraishe, S., Sealey, M. A., Samson, P. B., Mudher, A. K., & Wyttenbach, A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121534 · Cited by 23 · see citing works

Effects of HMG-CoA reductase inhibitors on learning and memory in the guinea pig

Maggo, S. D. S., & Ashton, J. C. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.11.018 · Cited by 21 · see citing works

Mechanisms and Clinical Evidence of the Pleiotropic Effects of the Hydroxy-Methyl-Glutaryl-CoA Reductase Inhibitors in Central Nervous System Disorders: A Comprehensive Review

Yanuck, D., Mihos, C. G., & Santana, O. (2012) · International Journal of Neuroscience · doi:10.3109/00207454.2012.704455 · Cited by 21 · see citing works

Exposure to 3-Nitropropionic Acid Mitochondrial Toxin Induces Tau Pathology in Tangle-Mouse Model and in Wild Type-Mice

Lahiani-Cohen, I., Touloumi, O., Lagoudaki, R., Grigoriadis, N., & Rosenmann, H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00321 · Cited by 21 · see citing works

Can the Treatment of Vascular Risk Factors Slow Cognitive Decline in Alzheimer's Disease Patients?

Richard, F., & Pasquier, F. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121012 · Cited by 20 · see citing works

Atorvastatin prevents Aβ oligomer-induced neurotoxicity in cultured rat hippocampal neurons by inhibiting Tau cleavage

Sui, H., Zhang, L., Liu, Z., & Jin, Y. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.161 · Cited by 17 · see citing works

Lovastatin suppresses the aberrant tau phosphorylation from FTDP-17 mutation and okadaic acid-induction in rat primary neurons

Li, R., Xu, D.-E., & Ma, T. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.005 · Cited by 15 · see citing works

Single‐molecule imaging reveals Tau trapping at nanometer‐sized dynamic hot spots near the plasma membrane that persists after microtubule perturbation and cholesterol depletion

Padmanabhan, P., Kneynsberg, A., Cruz, E., Amor, R., Sibarita, J., & Götz, J. (2022) · The EMBO Journal · doi:10.15252/embj.2022111265 · Cited by 15 · see citing works

Therapeutic strategies for tauopathies and drug repurposing as a potential approach

Islam, M., Shen, F., Regmi, D., & Du, D. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114979 · Cited by 14 · see citing works

Unraveling the Paradox of Statins with Human Neurons: New Leads in Alzheimer’s Disease

Blanchard, J., & Tsai, L. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.02.003 · Cited by 13 · see citing works

GRAMD1B is a regulator of lipid homeostasis, autophagic flux and phosphorylated tau

Ingram, D. A., Turkes, E., Kim, T. Y., Vo, S., Sweeney, N., Bonte, M.-A., Rutherford, R., Julian, D. L., Pan, M., Marsh, J. A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58585-w · Cited by 12 · see citing works

Atorvastatin Improves Mitochondrial Function and Prevents Oxidative Stress in Hippocampus Following Amyloid-β1–40 Intracerebroventricular Administration in Mice

Mancini, G., Martins, W. C., de Oliveira, J., Bem, A. F. D., & Tasca, C. I. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02026-w · Cited by 12 · see citing works

The Hybrid Compounds as Multi-target Ligands for the Treatment of Alzheimer's Disease: Considerations on Donepezil

Gülcan, H. O., & Koşar, M. (2021) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026621666211111153626 · Cited by 12 · see citing works

Pharmacological treatment for Alzheimer's disease: current approaches and future strategies.

Fan, L., & Chiu, M. (2010) · PubMed · Cited by 11 · see citing works

Novel disease-modifying therapeutics for the treatment of Alzheimer’s disease

Léger, G. C., & Massoud, F. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2013.811237 · Cited by 10 · see citing works

Activation of TRPV4 induces intraneuronal tau hyperphosphorylation via cholesterol accumulation

Du, K., Dou, Y., Chen, K., & Zhao, Y. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114392 · Cited by 10 · see citing works

Progressive Supranuclear Palsy and Statin Use

Bayram, E., Marras, C., Standaert, D. G., Kluger, B. M., Bordelon, Y. M., Shprecher, D., & Litvan, I. (2020) · Movement Disorders · doi:10.1002/mds.28038 · Cited by 9 · see citing works

Simvastatin, Its Antimicrobial Activity and Its Prevention of Alzheimer’s Disease

Dhakal, S., & Macreadie, I. G. (2024) · Microorganisms · doi:10.3390/microorganisms12061133 · Cited by 8 · see citing works

High-fat diet negatively affects brain markers, cognitive behaviors, and noncognitive behaviors in the rTg4510 tau mouse model

Lippi, S. L. P., Barkey, R. E., & Rodriguez, M. N. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114316 · Cited by 6 · see citing works

The Role of Tau Protein in Diseases

Das Bhaskar, C. (2018) · Annals of Advances in Chemistry · doi:10.29328/journal.aac.1001010 · Cited by 6 · see citing works

Pharmacological treatment for Alzheimer’s disease

Kulkantrakorn, K. (2014) · Asian Medical Journal and Alternative Medicine · doi:10.70933/2773-9465.1545 · Cited by 6 · see citing works

Lipid Metabolism and Statin Therapy in Neurodegenerative Diseases: An Endocrine View

Sarno, A. D., Romano, F., Arianna, R., Serpico, D., Lavorgna, M., Savastano, S., Colao, A., & Somma, C. D. (2025) · Metabolites · doi:10.3390/metabo15040282 · Cited by 5 · see citing works

EFFECT OF METFORMIN AND SIMVASTATIN IN DIAZEPAM-AND SODIUM NITRITE-INDUCED ANTEROGRADE AMNESIA IN MALE SWISS ALBINO MICE

Ss, T., & Sugato, C. H. (2018) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2018v10i6.19113 · Cited by 5 · see citing works

Enhanced Neuroprotective Synergy of Atorvastatin and Magnesium L-Threonate in a Rat Model of Alzheimer’s Disease Induced by Aluminum Chloride

Gangoda, D. M., Saiyed, M. S., Pathan, S. R., Sharma, K. B., Patel, V. A., Sachdeva, P. D., Patel, M. Y., & Patel, M. D. (2023) · Cureus · doi:10.7759/cureus.48400 · Cited by 5 · see citing works

Statins - From Lipid-Lowering Benefits to Pleiotropic Effects

Liu, D. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1001540 · Cited by 4 · see citing works

The in vivo effect of oil palm phenolics (OPP) in atherogenic diet induced rat model of Alzheimer's Disease (AD)

Wu, Y., Srirajavatsavai, V., Monplaisir, K. M., Sambanthamurthi, R., & Gupta, S. V. (2015) · The FASEB Journal · doi:10.1096/fasebj.29.1_supplement.271.8 · Cited by 3 · see citing works

In Search of Therapeutic Solutions for Alzheimer’s Disease

Ricardo, B., Faras, G., Leonel, E. C. R., & Jos, M. (2012) · InTech eBooks · doi:10.5772/34561 · Cited by 2 · see citing works

Stem Cell Therapy in Traumatic Brain Injury

Tu, S., & Tu, J. (2017) · Stem cells in clinical applications · doi:10.1007/978-3-319-33720-3_2 · Cited by 2 · see citing works

Statins and Reduction of Oxidative Stress in the Aged Brain

Kurata, T., Deguchi, K., Deguchi, S., Ikeda, Y., & Abe, K. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00069-0 · Cited by 2 · see citing works

Cholesterol and Dementia: A Possible Therapeutic Approach

Alavez-Rubio, J. S., & Juárez‐Cedillo, T. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_13 · Cited by 1 · see citing works

Contribution of Neural Membrane Phospholipids, Sphingolipids, and Cholesterol in the Pathogenesis of Alzheimer’s Disease

Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00003-3

A study of the global effects of Apolipoprotein E using lipidomics

Hawksworth, J. I. (2019) · ORCA Online Research @Cardiff (Cardiff University)

Faculty Opinions recommendation of Insulin resistance and neurodegeneration: progress towards the development of new therapeutics for alzheimer's disease.

Rosenzweig, S. A. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727123638.793572332

Causal relationship between cholesterol-lowering therapy and Alzheimer Disease: evidence from genetic correlation and Mendelian randomization studyPreprint

Huan, S., Gao, J., & Guoping, Y. I. N. (2023) · Research Square · doi:10.21203/rs.3.rs-2822676/v1

Statins’ Effects on Alzheimer’s Disease

Li, Q., Li, C.-N., & Chen, J. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1001286

Repurposing statins for different pathologies. A jack-of-all-trades drug?

Rodrigues-Díez, R. R., Muñoz, A. T., Márquez‐Expósito, L., & Ruiz‐Ortega, M. (2023) · Anales de la Real Academia Nacional de Farmacia · doi:10.53519/analesranf.2023.89.01.02

Healthy lifestyle and Alzheimer’s disease in individuals with hyperlipidemia: A prospective cohort study

Sun, D., Yu, L., Liao, C., Xu, Y., Liu, W., & Wang, X. (2026) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2026.100520

Progressive neurovascular disturbances in the cerebral cortex of Alzheimer's disease-model mice: protection by atorvastatin and pitavastatin

Kurata, T., Miyazaki, K., Kozuki, M., Morimoto, N., Ohta, Y., Ikeda, Y., & Abe, K. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.030 · Cited by 30 · see citing works

P1‐248: Atorvastatin and pitavastatin reduce senile plaques and inflammatory responses in model mice with Alzheimer's disease

Kurata, T., Miyazaki, K., Kozuki, M., Morimoto, N., Matsuzono, K., Ohta, Y., Ikeda, Y., & Abe, K. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.527 · Cited by 1 · see citing works

Statins have therapeutic potential for the treatment of Alzheimer's disease, likely via protection of the neurovascular unit in the AD brain

Kurata, T., Kawai, H., Miyazaki, K., Kozuki, M., Morimoto, N., Ohta, Y., Ikeda, Y., & Abe, K. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.06.011 · Cited by 31 · see citing works

P2–393: Progressive neurovascular disturbances in the cerebral cortex of Alzheimer's disease‐model mice: Protection by atorvastatin and pitavastatin

Kurata, T., Ohta, Y., Ikeda, Y., & Abe, K. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.05.1042

P3‐056: Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice

Abe, K., Kurata, T., Miyazaki, K., Kozuki, M., Morimoto, N., Ohta, Y., Ikeda, Y., & Matsuura, T. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.1495